TuHURA BIOSCIENCES, INC./NV Current Portion of Long-Term Debt
TuHURA BIOSCIENCES, INC./NV (HURA) had Current Portion of Long-Term Debt of $5 as of 2018-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LongTermDebtCurrent · last filed 2019-06-03
- 2018-03-31: Long-term Debt, Current Maturities $5.00.
- 2017-12-31: Long-term Debt, Current Maturities $95.00.
- 2017-09-30: Long-term Debt, Current Maturities $589.00.
- 2017-06-30: Long-term Debt, Current Maturities $33.09K.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2018-03-31 | $5.00 10-Q · filed 2019-05-14 |
| 2017-12-31 | $95.00 10-Q · filed 2019-02-11 |
| 2017-09-30 | $589.00 10-Q · filed 2018-11-13 |
| 2017-06-30 | $33.09K 8-K · filed 2019-06-03 |
| 2017-03-31 | -$157.15K 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |